<DOC>
	<DOCNO>NCT02755467</DOCNO>
	<brief_summary>To evaluate safety effectiveness laser treatment treatment spider angioma .</brief_summary>
	<brief_title>Clinical Evaluation Treatment Spider Angioma</brief_title>
	<detailed_description>The purpose study evaluate safety efficacy 532 nm KTP laser within Cutera Excel V system treatment spider angioma .</detailed_description>
	<mesh_term>Hemangioma</mesh_term>
	<criteria>1 . Males female , 5 65 year age ( inclusive ) . 2 . Fitzpatrick Skin Types IIV 3 . Subject must able read , understand sign Informed Consent Form . 4 . If subject minor ( &lt; 18 year old Illinois ) , Assent must obtain subject Parental Consent Form must sign parent legal guardian . 5 . Subject must willing able adhere treatment followup schedule posttreatment care instruction . 6 . Willing limited sun exposure duration study , include followup period . 7 . Willingness digital photograph take spider angioma ( ) agree use photograph presentation , educational marketing purpose 8 . Agree undergo procedure treatment spider angioma study . 1 . Pregnant . 2 . History pigmentary disorder , particularly tendency hyper hypopigmentation . 3 . Having know anticoagulative condition take anticoagulation medication , include aspirin . 4 . History seizure disorder due light . 5 . Systemic use isotretinoin ( AccutaneÂ® ) within 6 month study participation . 6 . Excessively tanned area treat unable/unlikely refrain tan study . 7 . Participation study another device drug within 3 month prior enrollment study . 8 . In opinion investigator , physical mental condition might make unsafe subject participate study require systemic therapy could interfere research study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>